VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Canadian National Railway Company vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Canadian National Railway Company
CNR · Toronto Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Canadian National Railway Company's moat claims, evidence, and risks.
View CNR analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Canadian National Railway Company leads (97 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Canadian National Railway Company has 2 segments (96.2% in Rail freight transportation network); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Canadian National Railway Company has 4 moat types across 2 domains; GSK plc has 4 across 3.
Primary market context
Canadian National Railway Company
Rail freight transportation network
Canadian Class I freight rail transportation
Canada (with U.S. cross-border corridors)
Industrial shippers, intermodal customers, and auto supply chains
Line-haul freight railway (Class I)
96.2%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Canadian National Railway Company strengths
GSK plc strengths
Segment mix
Canadian National Railway Company segments
Full profile >Rail freight transportation network
Duopoly
Non-rail logistics and ancillary services
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.